Related Experiment Videos

Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and

L A Sanni1, S R Thomas, B N Tattam

  • 1Department of Pathology, University of Sydney, New South Wales, Australia.

Insights

Cerebral malaria pathogenesis involves indoleamine 2,3-dioxygenase (IDO) induction and increased neurotoxin quinolinic acid (QA). Dexamethasone treatment inhibited IDO and prevented CM symptoms, suggesting QA

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • The pathogenesis of human cerebral malaria (CM) is not fully understood.
  • Murine models of CM require T lymphocytes and interferon-gamma (IFN-γ).
  • IFN-γ induces indoleamine 2,3-dioxygenase (IDO), a key enzyme in tryptophan metabolism.

Purpose of the Study:

  • To investigate the roles of IDO, kynurenine pathway metabolites, glutamate (Glu), and aspartate (Asp) in fatal murine CM.
  • To compare these roles in CM and noncerebral malaria (NCM) models.
  • To assess the effect of dexamethasone on IDO activity and CM progression.

Main Methods:

  • Plasmodium berghei ANKA infection in mice to model CM.
  • Plasmodium berghei K173 infection in mice to model NCM.
  • Biochemical analyses using high-pressure liquid chromatography and GC/MS/MS.
  • Assessment of IDO activity, metabolite concentrations, and neurological symptoms.

Main Results:

  • IDO activity was significantly induced in the brains of CM mice and later in NCM mice.
  • Dexamethasone inhibited IDO induction and prevented CM.
  • Increased brain concentrations of kynurenine, 3-hydroxykynurenine, and quinolinic acid (QA) were observed in CM and NCM.
  • An elevated QA to kynurenic acid (KA) ratio occurred specifically in CM mice with cerebral symptoms.
  • Brain Glu and Asp concentrations decreased in both CM and NCM mice.

Conclusions:

  • IDO induction and increased QA contribute to neuro-excitation and CM pathogenesis.
  • The QA/KA ratio may serve as a biomarker for CM.
  • Dexamethasone's efficacy suggests IDO inhibition as a potential therapeutic strategy.

Related Concept Videos